BS, MPH, DrPH, GradDipEco
Dr Sophy Shih is a health economist with demonstrated expertise in economic evaluation and health service research. She has extensive knowledge of designing and implementing trial-based economic assessments, performing economic evaluations, and building economic models. Dr Shih was trained in health economics, public health and biomedical science. She has worked on a broad range of topics including viral infection, rare genetic disease, cancer, diabetes, psycho-oncology, and disability with a focus on intervention research of prevention and screening.
Dr Shih joined the SERP Program at the Kirby Institute and the NPESU at the Centre for Big Data Research in Health as a Senior Research Fellow/Health Economist in 2019. Her current working program includes the TEMPO study, an RCT investigating HCV point of care testing to improve treatment uptake, cost-effectiveness analyses of HCV testing and treatment in NSW prisons, and the economic assessment of accelerating the uptake of initiatives to address HIV drug resistance surveillance in Papua New Guinea (ACTUP-PNG study).
Dr Shih was a subcommittee member of the Clinical Guidelines Network at Cancer Council Australia and co-authored the “Economics of Keratinocyte Cancer” chapter of the NHMRC endorsed clinical guidelines “Clinical Practice Guidelines for Keratinocyte Cancer”.